Preparing for All Hazards and Pathogens Reauthorization Act

To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes. 1. Short title; table of contents (a) Short title This Act may be cited as the Preparing for All Hazards and Pathogens Reauthorization Act (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Title I—Preparing for and responding to public health security threats Sec. 101. National health security strategy. Sec. 102. Protection of national security from threats. Sec. 103. Public Health Emergency Medical Countermeasures Enterprise. Sec. 104. Partnerships for State and regional hospital preparedness to improve surge capacity. Sec. 105. Guidelines for regional health care emergency preparedness and response systems. Sec. 106. Strategic National Stockpile. Sec. 107. Diagnostic testing preparedness plan. Sec. 108. Biomedical advanced research and development authority. Sec. 109. Ensuring collaboration and coordination in medical countermeasure development. Sec. 110. Review of ASPR efforts to ensure supply chain resiliency and accountability. Sec. 111. Review of HHS efforts to ensure rapid production and domestic manufacturing capacity of medical countermeasures. Sec. 112. Crisis standards of care. Title II—Ensuring workforce to prepare for and respond to public health security threats Sec. 201. Emergency system for advance registration of volunteer health professional. Sec. 202. Military and civilian partnership for trauma readiness. Sec. 203. National advisory committees on disasters. Sec. 204. National Disaster Medical System. Sec. 205. Volunteer Medical Reserve Corps. I Preparing for and responding to public health security threats 101. National health security strategy (a) Public health workforce Section 2802(a)(3) of the Public Health Service Act ( 42 U.S.C. 300hh–1(a)(3) In 2022, the The (b) Medical and public health community preparedness goal Section 2802(b)(8)(A) of the Public Health Service Act ( 42 U.S.C. 300hh–1(b)(8)(A) , including by protecting against cybersecurity threats 102. Protection of national security from threats Section 2811(f)(2)(A) of the Public Health Service Act ( 42 U.S.C. 300hh–10(f)(2)(A) $250,000,000 for each of fiscal years 2019 through 2023 $327,991,000 for each of fiscal years 2024 through 2028 103. Public Health Emergency Medical Countermeasures Enterprise (a) Members Section 2811–1(b) of the Public Health Service Act (42 U.S.C. 30hh–10a(b)) is amended by striking paragraph (11) and inserting the following: (11) The Director of the Biomedical Advanced Research and Development Authority. (12) The Director of the Strategic National Stockpile. (13) Representatives of any other Federal agency, which may include the Director of the National Institute of Allergy and Infectious Diseases and the Director of the Office of Public Health Preparedness and Response, as the Secretary determines appropriate. . (b) Functions Section 2811–1(c)(2) of the Public Health Service Act (42 U.S.C. 30hh–10a(c)(2)) is amended to read as follows: (2) Input In carrying out this section, the PHEMCE shall solicit and consider input from— (A) the PHEMCE Advisory Committee maintained under subsection (d), as appropriate; and (B) State, local, Tribal, and territorial public health departments or officials, as appropriate. . (c) Advisory committee Section 2811–1 of the Public Health Service Act ( 42 U.S.C. 30hh–10a (d) PHEMCE Advisory Committee (1) Establishment The Secretary shall— (A) establish and maintain an advisory committee to be known as the PHEMCE Advisory Committee (in this subsection referred to as the Advisory Committee (B) seek input from and consult with external partners with divergent threat portfolios, including chemical, biological, radiological, or nuclear agents and emerging infectious diseases, to ensure the right combination of threat-specific expertise on PHEMCE functions under subsection (c)(1) and to ensure appropriate capability and capacity to maintain overall readiness. (2) Duties The Advisory Committee shall— (A) provide advice to the PHEMCE in carrying out its functions; (B) solicit and incorporate the input of the private sector, non-Federal partners, and stakeholders to increase communication and transparency, identify gaps of preparedness, and coordinate improvements in PHEMCE decision-making (C) aid in the PHEMCE’s strategic planning and decision-making regarding medical countermeasure research, advanced research, development, procurement, stockpiling, replenishment, deployment, and distribution; (D) aid in interactions among the PHEMCE’s members listed in subsection (b) and other government entities; and (E) aid in the PHEMCE’s communication of decisions related to the PHEMCE’s functions. (3) Membership The Secretary, in consultation with the members of the PHEMCE listed in subsection (b), shall appoint to the Advisory Committee at least 9, and not more than 15, individuals, including— (A) at least 3 non-Federal professionals with expertise in medical countermeasure development, including medical countermeasures for chemical, biological, radiological, or nuclear agents and emerging infectious diseases; (B) at least 2 non-Federal professionals with expertise in medical countermeasure stockpiling and replenishment; (C) at least 2 non-Federal professionals with expertise in the medical countermeasure supply chain, including medical countermeasure manufacturing and distribution; (D) at least 2 non-Federal professionals with expertise in medical disaster planning, preparedness, response, or recovery; (E) 1 non-Federal professional appointed by the Speaker of the House of Representatives; (F) 1 non-Federal professional appointed by the minority leader of the House of Representatives; (G) 1 non-Federal professional appointed by the majority leader of the Senate; and (H) 1 non-Federal professional appointed by the minority leader of the Senate. (4) Term of appointment Each member of the Advisory Committee shall be appointed for a term of 2 years and may be reappointed for two additional terms of 2 years, for a total of not more than 6 years. The first and second such terms may be consecutive. The third such term may not be consecutive. (5) Meetings The Advisory Committee shall— (A) meet not less than 4 times in each calendar year that begins after the establishment of the Advisory Committee; (B) hold all meetings in-person; (C) for purposes of ensuring transparency, provide adequate advance notice of the date of each meeting, including by publicly posting the meeting date 30 days before the date on which the meeting is to be held; (D) not later than 60 days after each meeting, communicate the activities carried out and decisions made during, and minutes of, such meeting to the appropriate congressional committees; and (E) not later than 30 days after each meeting, communicate the activities carried out and decisions made during, and minutes of, such meeting to the PHEMCE. . 104. Partnerships for State and regional hospital preparedness to improve surge capacity (a) Authorization of appropriations Section 319C–2(j)(1)(A) of the Public Health Service Act (42 U.S.C. 247d–3b(j)(1)(A)) is amended by striking 2019 through 2023 2024 through 2028 (b) Sunset Section 319C–2(j)(1)(B)(iii) of the Public Health Service Act (42 U.S.C. 247d–3b(j)(1)(B)(iii)) is amended by striking 2023 2028 105. Guidelines for regional health care emergency preparedness and response systems (a) Guidelines Section 319C–3(b)(3) of the Public Health Service Act (42 U.S.C. 247d–3c(b)(3)) is amended by striking the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (including any amendments made by such Act) the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, the PREVENT Pandemics Act (title II of division FF of Public Law 117–328 Preparing for All Hazards and Pathogens Reauthorization Act (b) Demonstration project for regional health care preparedness and response systems Section 319C–3(e)(2) of the Public Health Service Act (42 U.S.C. 247d–3c(e)(2)) is amended by striking 2023 2028 106. Strategic National Stockpile (a) Responsibility for administering the Strategic National Stockpile (1) Transfer (A) In general Section 319F–2(a)(1) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(1)) is amended by striking The Secretary, in collaboration with the Assistant Secretary for Preparedness and Response and the Director of the Centers for Disease Control and Prevention, and in coordination with the Secretary of Homeland Security The Secretary, acting through the Assistant Secretary for Preparedness and Response, in coordination with the Director of the Centers for Disease Control and Prevention and the Secretary of Homeland Security (B) Conforming amendment Section 319F–2(a)(3)(E) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(3)(E)) is amended by striking the Assistant Secretary for Preparedness and Response, (C) Pilot program to support State medical stockpiles Section 319F–2(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6b(i)(1)) is amended by striking The Secretary, in consultation with the Assistant Secretary for Preparedness and Response and the Director of the Centers for Disease Control and Prevention The Secretary, acting through the Assistant Secretary for Preparedness and Response, in consultation with the Director of the Centers for Disease Control and Prevention (D) Transition The Secretary of Health and Human Services shall take such actions as may be necessary to ensure that, not later than 180 days after the date of enactment of this Act, the amendments made by this subsection are fully implemented, including any necessary transfer of personnel and resources. (2) ASPR authorities (A) Additional coordination duty Section 2811(b)(4) of the Public Health Service Act (42 U.S.C. 247d–6b(b)) is amended by adding at the end the following: (K) Strategic National Stockpile Coordinate with the Director of the Centers for Disease Control and Prevention and the Secretary of Homeland Security regarding the maintenance and operation of, and procurement and contracting related to, the Strategic National Stockpile under section 319F–2. . (B) Additional responsibility (i) In general Section 2811(c)(2) of the Public Health Service Act (42 U.S.C. 247d–6b(c)(2)) is amended— (I) by redesignating subparagraphs (E) and (F) as subparagraphs (F) and (G), respectively; and (II) by inserting after subparagraph (D) the following: (E) the Strategic National Stockpile pursuant to section 319F–2; . (ii) Conforming changes Section 2811(c)(3) of the Public Health Service Act (42 U.S.C. 247d–6b(c)(3)) is amended— (I) in subparagraph (A), by inserting and (II) by striking subparagraph (B); and (III) by redesignating subparagraph (C) as subparagraph (B). (b) Vendor-Managed inventory and warm-Based surge capacity contracts and cooperative agreements with clinical laboratories Section 319F–2(a)(5)(A) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(5)(A)) is amended— (1) by inserting after contracts or cooperative agreements with vendors, which may include manufacturers or distributors of medical products, as well as clinical laboratories, (2) in clause (ii), by striking domestic manufacturing capacity domestic manufacturing and laboratory capacity (c) Contract notification Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following: (8) Procurement contract duration (A) In general A contract for the procurement of a drug, vaccine or other biological product, medical device, or other supplies for the stockpile under paragraph (1) shall be for a period not to exceed five years, except that, in first awarding the contract, the Secretary may provide for a longer duration, not exceeding 10 years, if the Secretary determines that complexities or other difficulties in performance under the contract justify such a period. The contract shall be renewable for additional periods, none of which shall exceed five years. (B) Notification The Secretary shall notify— (i) the Committee on Appropriations and the Committee on Energy and Commerce of the House of Representatives and the Committee on Appropriations and the Committee on Health, Education, Labor, and Pensions of the Senate upon a determination by the Secretary to modify, renew, extend, or terminate a contract referred to in subparagraph (A); and (ii) the relevant vendor within 90 days of a determination by the Secretary to modify, renew, extend, or terminate such a contract. . (d) Authorization of appropriations (1) In general Section 319F–2(f) of the Public Health Service Act (42 U.S.C. 247d–6b(f)) is amended— (A) in paragraph (1), by striking $610,000,000 for each of fiscal years 2019 through 2021, and $750,000,000 for each of fiscal years 2022 and 2023 $965,000,000 for each of fiscal years 2024 through 2028 (B) by striking paragraph (2); and (C) by striking Authorization of appropriations For the purpose of carrying out subsection (a), there are authorized to be appropriated Authorization of appropriations (2) Pilot program to support State medical stockpiles Section 319F–2(i)(9) of the Public Health Service Act (42 U.S.C. 247d–6b(i)(9)) is amended by striking 2024 2028 107. Diagnostic testing preparedness plan The Public Health Service Act ( 42 U.S.C. 201 et seq. 42 U.S.C. 247d–6f 319F–6. Diagnostic testing preparedness plan (a) In general The Secretary, acting through the Assistant Secretary for Preparedness and Response, and in consultation with the heads of relevant Federal agencies, shall develop not later than 1 year after the date of enactment of this section and update not less than every 3 years thereafter a plan for rapid development, authorization, scaling, procurement, and distribution of diagnostics and clinical and diagnostic laboratory testing capacity during a public health emergency declared under section 319. (b) Purposes The purposes of the plan under subsection (a) shall be— (1) to facilitate the development and utilization of diagnostics for use with respect to a novel chemical, biological, radiological, or nuclear threat or an emerging infectious disease, including any such high-throughput laboratory diagnostic, point-of-care diagnostic, or rapid at-home or point-of-use diagnostic; and (2) to describe the processes for rapid development, authorization, scaling, procurement, and distribution of diagnostics and clinical and diagnostic laboratory testing capacity. (c) Public-Private coordination (1) In general The Secretary, acting through the Assistant Secretary for Preparedness and Response, shall include within the plan under subsection (a) a plan for public-private coordination on national diagnostic testing during a public health emergency. (2) Contents The plan under paragraph (1) shall be designed to facilitate coordination and collaboration among— (A) government agencies; and (B) critical private-sector diagnostic testing stakeholders, including private-sector clinical and diagnostic laboratories, diagnostic manufacturers, health care product distributors, and research laboratories. (d) Public availability The Secretary, acting through the Assistant Secretary for Preparedness and Response, shall make the plan under subsection (a) publicly available. (e) Reports to Congress Not later than 1 year after commencing implementation of the plan under subsection (a) for a public health emergency, the Secretary, acting through the Assistant Secretary for Preparedness and Response, shall submit to the Congress a report evaluating the effectiveness of activities implemented under the plan. . 108. Biomedical advanced research and development authority (a) Medical countermeasures for viral threats with pandemic potential Section 319L(c)(4) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(4)) is amended— (1) in subparagraph (D)— (A) in clause (ii), by striking ; and (B) by redesignating clause (iii) as clause (v); and (C) by inserting after clause (ii) the following: (iii) the identification and development of platform manufacturing technologies needed for advanced development and manufacturing of medical countermeasures for viral families which have significant potential to cause a pandemic; (iv) advanced research and development of flexible medical countermeasures against priority respiratory virus families and other respiratory viral pathogens with a significant potential to cause a pandemic, with both pathogen-specific and pathogen-agnostic approaches; and ; and (2) in subparagraph (F)— (A) in clause (ii), by striking ; and (B) in clause (iii), by striking the period and inserting ; and (C) by adding at the end the following: (iv) priority virus families and other viral pathogens with a significant potential to cause a pandemic. . (b) Contract notification Section 319L(c)(5) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(5)) is amended by adding at the end the following: (I) Duration A contract, grant, cooperative agreement, or other transaction entered into under this section shall be for a period not to exceed five years, except that, in first awarding the grant or entering into the contract, cooperative agreement, or other transaction, the Secretary may provide for a longer duration, not exceeding 10 years, if the Secretary determines that complexities or other difficulties in performance under the contract, grant, cooperative agreement, or other transaction justify such a period. The contract, grant, cooperative agreement, or other transaction shall be renewable for additional periods, none of which shall exceed five years. The Secretary shall notify the vendor within 90 days of a determination by the Secretary to modify, renew, extend, or terminate such contract, grant, cooperative agreement, or other transaction. . (c) Authorization of appropriations Section 319L(d)(2) of the Public Health Service Act (42 U.S.C. 247d–7e(d)(2)) is amended by striking $611,700,000 for each of fiscal years 2019 through 2023 $950,000,000 for each of fiscal years 2024 through 2028 (d) Inapplicability of certain provisions sunset Section 319L(e)(1)(D) of the Public Health Service Act (42 U.S.C. 247d–7e(e)(1)(D)) is amended by striking on the date that is 17 years after the date of enactment of the Pandemic and All-Hazards Preparedness Act on October 1, 2028 109. Ensuring collaboration and coordination in medical countermeasure development Section 319L–1(b) of the Public Health Service Act (42 U.S.C. 274d–7f(b)) is amended by striking at the end of the 17-year period that begins on the date of enactment of this Act on October 1, 2028 110. Review of ASPR efforts to ensure supply chain resiliency and accountability (a) In general Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall complete a review of— (1) the Supply Chain Control Tower Program (in this section referred to as the SCCT Program (2) any related efforts of the Administration for Strategic Preparedness and Response— (A) to create supply chain visibility into inventory, capacity, and distribution flow of certain products critical to preparedness and response efforts; (B) to provide insights into demand forecasting and modeling of certain products critical to preparedness and response efforts; or (C) to inform preparedness and response efforts by targeting distribution and coordinating supply with demand for certain products critical to preparedness and response efforts. (b) Issues The review under this section shall include examination of— (1) the data being collected and maintained pursuant to the SCCT Program; (2) how the Department of Health and Human Services, acting through the Administration for Strategic Preparedness and Response, uses such data to provide supply chain visibility and address actual or potential supply gaps; (3) the extent to which such data is provided and shared with end users, including States, localities, Territories, Tribes, and industry partners; (4) the frequency and cadence of data reporting and sharing by and among States, localities, Territories, Tribes, and industry partners; (5) information related to the type and number of States, localities, Territories, Tribes, and industry partners participating in the SCCT Program; (6) the process by which States, localities, Territories, Tribes, and industry partners voluntarily choose to participate in the SCCT Program; and (7) any inefficiencies, deficiencies, or challenges related to the application or operation of the SCCT Program. (c) Report to Congress Not later than the deadline described in subsection (a) for the completion of the review under this section, the Comptroller General shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the results of such review. 111. Review of HHS efforts to ensure rapid production and domestic manufacturing capacity of medical countermeasures (a) In general Not later than 1 year after the date of the enactment of this Act, the Comptroller General of the United States shall conduct and complete a review examining the efforts of the Secretary of Health and Human Services to ensure that the United States is prepared to rapidly produce qualified countermeasures (as defined in section 319F–1 of the Public Health Service Act ( 42 U.S.C. 247d–6a 42 U.S.C. 274d (b) Contents The review conducted under subsection (a) shall include a review of— (1) the efforts described in such subsection, including the Secretary’s efforts to transition from the Centers for Innovation and Advanced Drug Manufacturing program to any new efforts, including the National Biopharmaceutical Manufacturing Partnership and Industrial Base Expansion Connect; (2) the progress made toward the implementation of such efforts; and (3) the planning within the Department of Health and Human Services to assess risks and challenges associated with advanced development and manufacturing of qualified countermeasures. (c) Report to Congress Not later than 1 year after completing the review under subsection (a), the Comptroller General of the United States shall submit to the Congress a report containing— (1) the results of the review; and (2) the Comptroller General’s recommendations for ensuring that the United States is prepared to rapidly produce qualified countermeasures in the event of a public health emergency. 112. Crisis standards of care Not later than 2 years after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Director of the Office for Civil Rights of the Department of Health and Human Services, shall issue guidance on how to develop or modify State and local crisis standards of care for use during an emergency period (as defined in section 1135(g)(1) of the Social Security Act ( 42 U.S.C. 1320b–5(g)(1) 29 U.S.C. 794 II Ensuring workforce to prepare for and respond to public health security threats 201. Emergency system for advance registration of volunteer health professional (a) In general Section 319I(a) of the Public Health Service Act ( 42 U.S.C. 247d–7b Not later than 12 months after the date of enactment of the Pandemic and All-Hazards Preparedness Act, the Secretary shall link existing State verification systems to maintain The Secretary shall continue to maintain (b) Authorization of appropriations Section 319I(k) of the Public Health Service Act (42 U.S.C. 247d–7b(k)) is amended by striking 2019 through 2023 2024 through 2028 202. Military and civilian partnership for trauma readiness Section 1291(g) of the Public Health Service Act ( 42 U.S.C. 300d–91(g) 2019 through 2023 2024 through 2028 203. National advisory committees on disasters (a) National Advisory Committee on Children and Disasters Subsection (g) of section 2811A of the Public Health Service Act ( 42 U.S.C. 300hh–10b (g) Sunset (1) In general The Advisory Committee shall terminate on September 30, 2028. (2) Extension of committee Not later than October 1, 2027, the Secretary shall submit to Congress a recommendation on whether the Advisory Committee should be extended. . (b) National Advisory Committee on Seniors and Disasters Section 2811B of the Public Health Service Act ( 42 U.S.C. 300hh–10c (1) in subsection (d)— (A) in paragraph (1), by striking in consultation with such other heads of agencies as appropriate, shall appoint not more than 17 members in consultation with such other Secretaries as may be appropriate, shall appoint not more than 23 members (B) by redesignating paragraph (2) as paragraph (3); (C) by amending paragraph (3), as so redesignated— (i) in the paragraph heading, by striking Required members Required Federal members (ii) in the matter preceding subparagraph (A), by striking and non-Federal members, (iii) by striking subparagraphs (J) and (K); and (iv) by redesignating subparagraph (L) as subparagraph (J); (D) by inserting after paragraph (1) the following new paragraph: (2) Required non-Federal members The Secretary, in consultation with such other heads of Federal agencies as may be appropriate, shall appoint to the Advisory Committee under paragraph (1) at least 13 individuals, including— (A) at least 4 non-Federal health care providers with expertise in geriatric medical disaster planning, preparedness, response, or recovery; (B) at least 3 representatives of State, local, Tribal, or territorial agencies with expertise in geriatric disaster planning, preparedness, response, or recovery; and (C) at least 4 non-Federal professionals with training in gerontology, including social workers, scientists, human services specialists, or other non-medical professionals, with experience in disaster planning, preparedness, response, or recovery among other adults. ; and (E) by adding at the end the following new paragraphs: (4) Term of appointment Each member of the Advisory Committee appointed under paragraph (2) shall serve for a term of 3 years, except that the Secretary may adjust the terms of the Advisory Committee appointees serving on the date of enactment of the Preparing for All Hazards and Pathogens Reauthorization Act (5) Consecutive appointments; maximum terms A member appointed under paragraph (2) may serve not more than 3 terms on the Advisory Committee, and not more than 2 of such terms may be served consecutively. ; and (2) in subsection (g)— (A) in paragraph (1), by striking 2023 2028 (B) in paragraph (2), by striking 2022 2027 (c) National Advisory Committee on Individuals with Disabilities Section 2811C of the Public Health Service Act ( 42 U.S.C. 300hh–10d (1) by redesignating subsections (c) through (g) as subsections (d) through (h), respectively; (2) by inserting after subsection (b) the following new subsection: (c) Additional duties The Advisory Committee may provide advice and recommendations to the Secretary with respect to individuals with disabilities, and medical and public health grants and cooperative agreements, as applicable to preparedness and response activities under this title and title III. ; (3) in subsection (d), as so redesignated— (A) in paragraph (1), by striking in consultation with such other heads of agencies and departments as appropriate, shall appoint not more than 17 members in consultation with such other Secretaries as may be appropriate, shall appoint not more than 23 members (B) by redesignating paragraph (2) as paragraph (3); (C) by amending paragraph (3), as redesignated— (i) in the paragraph heading, by striking Required members Required Federal members (ii) in the matter preceding subparagraph (A), by striking and non-Federal members, (iii) by striking subparagraph (K) and inserting the following: (K) Representatives of such other Federal agencies as the Secretary determines necessary to fulfill the duties of the Advisory Committee. ; and (iv) by striking subparagraphs (L) and (M); (D) by inserting after paragraph (1) the following new paragraph: (2) Required non-Federal members The Secretary, in consultation with such other heads of Federal agencies as may be appropriate, shall appoint to the Advisory Committee under paragraph (1) at least 13 individuals, including— (A) at least 4 non-Federal health care professionals with expertise in disability accessibility before, during, and after disasters, medical and mass care disaster planning, preparedness, response, or recovery; (B) at least 3 representatives from State, local, Tribal, or territorial agencies with expertise in disaster planning, preparedness, response, or recovery for individuals with disabilities; and (C) at least 4 individuals with a disability with expertise in disaster planning, preparedness, response, or recovery for individuals with disabilities. ; and (E) by adding at the end the following new paragraphs: (4) Term of appointment Each member of the Advisory Committee appointed under paragraph (2) shall serve for a term of 3 years, except that the Secretary may adjust the terms of the Advisory Committee appointees serving on the date of enactment of the Preparing for All Hazards and Pathogens Reauthorization Act (5) Consecutive appointments; maximum terms A member appointed under paragraph (2) may serve not more than 3 terms on the Advisory Committee, and not more than 2 of such terms may be served consecutively. ; and (4) in subsection (g)— (A) in paragraph (1), by striking 2023 2028 (B) in paragraph (2), by striking 2022 2027 204. National Disaster Medical System (a) Elimination of sunset of authority To make certain appointments for National Disaster Medical System Section 2812(c)(4) of the Public Health Service Act ( 42 U.S.C. 300hh–11(c)(4) (1) by striking (A) If the Secretary determines (2) by striking subparagraph (B). (b) Authorization of appropriations Section 2812(g) of the Public Health Service Act ( 42 U.S.C. 300hh–11(g) $57,400,000 for each of fiscal years 2019 through 2023 $96,904,000 for each of fiscal years 2024 through 2028 205. Volunteer Medical Reserve Corps Section 2813(i) of the Public Health Service Act ( 42 U.S.C. 300hh–15(i) 2019 through 2023 2024 through 2028

Summary: Preparing for All Hazards and Pathogens Reauthorization ActThis bill reauthorizes through FY2028 and modifies public health preparedness and response programs and activities.This includesinitiatives of the Administration for Strategic Preparedness and Response to address public health or national security threats, such as pandemic influenza;the Hospital Preparedness Program and other efforts to enhance the capacity of the health care system to respond to threats and emergencies; andvarious programs to support the response of volunteer health care providers and other professionals to disasters and emergencies (e.g., the Volunteer Medical Reserve Corps).